This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Satoshi Toda: Innovator in Transcriptional Switch Technologies
Introduction
Satoshi Toda is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of transcriptional switch technologies. With a total of 2 patents, his work has the potential to impact various applications in genetic engineering and synthetic biology.
Latest Patents
Satoshi Toda's latest patents include innovations related to binding-triggered transcriptional switches and methods of use thereof. These patents provide detailed descriptions of binding-triggered transcriptional switch polypeptides, nucleic acids that encode these polypeptides, and genetically modified host cells. Additionally, the patents cover chimeric Notch receptor polypeptides and the corresponding nucleic acids. The transgenic organisms that incorporate these innovations are designed to enhance the functionality of genetic switches, making them useful in a variety of applications.
Career Highlights
Satoshi Toda is affiliated with the University of California, where he continues to advance his research in biotechnology. His work has garnered attention for its innovative approach to genetic modification and its potential applications in medicine and agriculture.
Collaborations
Satoshi has collaborated with notable colleagues in his field, including Wendell A Lim and Leonardo Morsut. These collaborations have further enriched his research and contributed to the development of groundbreaking technologies.
Conclusion
Satoshi Toda's contributions to the field of biotechnology through his patents and research at the University of California highlight his role as an influential inventor. His work on binding-triggered transcriptional switches is paving the way for future advancements in genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
